Joint Annual Meeting ISMRM-ESMRMB • 16-21 June 2018 • Paris, France

Sunrise Session
From Diagnosis to Assessing Therapy Response: Gynecological Malignancy
From Diagnosis to Assessing Therapy Response: Gynecological Malignancy
Sunrise Session

ORGANIZERS: Kathryn Fowler, Catherine Hines, Kartik Jhaveri, Lorenzo Mannelli, Valeria Panebianco, Scott Reeder, Reiko Woodhams

 
Tuesday, 19 June 2018
S01  07:00 - 07:50 Moderators:  Victoria Chernyak, Jeffrey Brown

Skill Level: Basic to Intermediate
Session Number: S-Tu-01

Overview
This course discusses findings of gynecological malignancy on MRI. The process of staging and monitoring the chemotherapy response based on MRI findings is the main topic. This course will discuss how to optimize image acquisition for state of the art image quality and as short as possible scan time.

Target Audience
This course is aimed at radiologists, imaging scientists, and MR technologists who wish to learn about gynecological malignancy and the use of MRI for evaluation of these diseases.

Educational Objectives
As a result of attending this course, participants should be able to:
-Describe a high-quality gynecological malignancy MRI protocol;
-Explain the MRI findings involved in diagnosing gynecological malignancy; 
-Demonstrate gynecological malignancy staging based on MRI findings; and
-Illustrate the findings of response to chemotherapy.
 

 

 
07:00
 		   Pre-Treatment
Andrea Rockall
07:25
 		   Monitoring response to therapy
Nandita deSouza
Meaningful biomarkers/biomarker combinations for response assessment in gynecological malignancy must be i) derived to a specified standard, ii) of known accuracy, iii) sensitive to a specific treatment class and iv) measured at an appropriate time within the treatment pathway.

 
07:50
 		   Adjournment & Meet the Teachers
Back
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.